<DOC>
	<DOCNO>NCT02324270</DOCNO>
	<brief_summary>To demonstrate therapeutic efficacy generic diclofenac epolamine patch Flector patch treatment pain subject minor ankle sprain</brief_summary>
	<brief_title>Safety Efficacy Generic Diclofenac Epolamine Acute Pain Due Minor Ankle Sprain</brief_title>
	<detailed_description>To evaluate therapeutic equivalence safety generic diclofenac epolamine 1.3 % patch ( Watson Laboratories , Inc. ) Flector® ( diclofenac epolamine 1.3 % patch ) ( Pfizer ) treatment acute pain due minor ankle sprain . To demonstrate superiority efficacy test reference product vehicle control treatment acute pain due minor ankle sprain . To access application site reaction patch adhesion treatment group .</detailed_description>
	<mesh_term>Acute Pain</mesh_term>
	<mesh_term>Ankle Injuries</mesh_term>
	<mesh_term>Sprains Strains</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Diclofenac hydroxyethylpyrrolidine</mesh_term>
	<criteria>1 . Male Non pregnant female , 1865 year age 2 . Signed informed consent obtain meet criteria current FDA Health Insurance Portability Accountability Act regulation 3 . Subject diagnosis uncomplicated acute minor ankle sprain : Grade I II ( define America Academy Orthopedic Surgeons AAOS ) 4 . Ankle sprain must occur &lt; 48 hour study entry baseline pain score &gt; 50 mm 100 mm Visual Analog Scale ( VAS ) upon active mobilization 5 . Female subject childbearing potential ( exclude woman surgically sterilize postmenopausal least 1 year ) , addition negative urine pregnancy test , must willing use acceptable form birth control study day first dose administration 30 day last administration study drug . For purpose study follow consider acceptable method birth control : oral injectable contraceptive , contraceptive patch , DepoProvera® ( stable treatment least 3 month ) NuvaRing® ( vaginal contraceptive ) ; Implanon™ ( contraceptive implant ) double barrier method ( e.g . condom spermicide ) , intrauterine device , abstinence 2nd acceptable method birth control , patient become sexually active . A sterile sexual partner NOT consider adequate form birth control . 6 . All male subject must agree use accept method birth control partner , day first dose administration 30 day last administration study drug . Abstinence acceptable method birth control . Female partner use acceptable method birth control describe Item Number 5 . 7 . Subject free systemic dermatologic disorder , opinion investigator , interfere study result increase risk adverse event . 8 . Subject show willingness capability cooperate extent degree require protocol . 9 . Subject willing refrain use pain medication participation . 1 . Pregnant breastfeed female . 2 . Sprain occur &gt; 48 hour prior study enrollment . 3 . Ankle sprain require orthopedic surgical treatment . 4 . Ankle sprain treat prior study entry topical , oral , parenteral nonsteroidal antiinflammatory drug ( NSAID ) , physiotherapy , ultrasound , physical therapy acupuncture . 5 . Baseline selfevaluation pain active mobilization VAS &lt; 50 mm . 6 . Nonintact damage skin within area treat , e.g. , eczema , psoriasis , exudative , dermatitis , infected lesion , burn wound . 7 . Medical history asthma , urticaria , angioedema , bronchospasm , ulcer disease , gastrointestinal bleeding , hypertension , edema , heart failure cardiovascular disease . 8 . Medical history chronic pain disorder . 9 . Coagulation defect . 10 . Severe cardiac , renal hepatic impairment . 11 . Severe systemic disease ( e.g. , cancer , severe acute infection ) . 12 . Use within one month prior randomization 1 . ) immunomodulators immunosuppressive therapy , 2 . ) interferon , 3 . ) oral parenteral corticosteroid 4 . ) cytotoxic drug . 13 . Use within 7 day prior randomization topical agent affect ankle . 14 . Use within 7 day prior randomization topical , oral parenteral treatment NSAIDs aspirin . 15 . Use within 12 hour prior randomization analgesic . Eg . Acetaminophen ( Tylenol® ) . 16 . Known allergy hypersensitivity diclofenac , aspirin NSAIDs , excipient test product brand product ( Flector ) . 17 . History uncontrolled chronic acute concomitant disease , Investigator 's opinion , would contraindicate study participation confound interpretation result .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Pain due ankle sprain</keyword>
</DOC>